Human Albumin
制剂 FDF · — · 5g/vial (5%, 100mL); 5g/vial (20%, 25mL); 10g/vial (20%, 50mL); 12.5g/vial (25%, 50mL)
制剂 FDFConfidentiality：公开
- INN / Generic Name
- Human Albumin
- Dosage Form
- —
- Strength
- 5g/vial (5%, 100mL); 5g/vial (20%, 25mL); 10g/vial (20%, 50mL); 12.5g/vial (25%, 50mL)
- Therapy Area
- Cardiovascular
- Indication
- Hypovolaemic shock; Intracranial pressure increased; Oedema; Ascites; Hypoproteinaemia; Hyperbilirubinaemia neonatal; Cardiopulmonary bypass; Burn; Haemodialysis; Acute respiratory distress syndrome
- Current Status
- 官方 FDF 授权目录（UB133）
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- 已完成注册（目标市场可转移 / 视市场 DCP·NP）
- MOQ
- 询价
- Lead Time
- 询价
- Price Range
- 询价
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price
- —